Allergy Therapeutics PLC
LSE:AGY
Allergy Therapeutics PLC
LSE:AGY
Price:
11.3
GBX
-0.88%
Market Closed
Market Cap:
£694m
Balance Sheet
Balance Sheet Decomposition
Allergy Therapeutics PLC
Allergy Therapeutics PLC
Balance Sheet Decomposition is not available for
Allergy Therapeutics PLC
Allergy Therapeutics PLC
Balance Sheet
Allergy Therapeutics PLC
Allergy Therapeutics PLC
Currency: GBP
| Jun-2002 | Jun-2003 | Jun-2004 | Jun-2005 | Jun-2006 | Jun-2007 | Jun-2008 | Jun-2009 | Jun-2010 | Jun-2011 | Jun-2012 | Jun-2013 | Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | Jun-2023 | Jun-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
1
|
1
|
15
|
24
|
6
|
2
|
0
|
5
|
1
|
1
|
1
|
2
|
21
|
23
|
22
|
16
|
27
|
37
|
40
|
21
|
15
|
13
|
13
|
|
| Cash |
0
|
1
|
1
|
15
|
24
|
6
|
2
|
0
|
5
|
1
|
1
|
1
|
2
|
21
|
23
|
22
|
16
|
27
|
37
|
40
|
21
|
15
|
13
|
13
|
|
| Total Receivables |
1
|
1
|
2
|
3
|
2
|
3
|
3
|
2
|
3
|
6
|
4
|
5
|
4
|
4
|
6
|
6
|
5
|
8
|
6
|
5
|
6
|
5
|
6
|
6
|
|
| Accounts Receivables |
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
5
|
4
|
4
|
4
|
4
|
3
|
3
|
2
|
3
|
3
|
|
| Other Receivables |
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
3
|
1
|
2
|
1
|
1
|
1
|
2
|
2
|
4
|
2
|
2
|
3
|
3
|
3
|
3
|
|
| Inventory |
2
|
2
|
2
|
3
|
4
|
5
|
6
|
6
|
7
|
7
|
7
|
6
|
6
|
7
|
8
|
7
|
9
|
9
|
10
|
11
|
11
|
12
|
13
|
14
|
|
| Other Current Assets |
0
|
1
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
1
|
2
|
1
|
2
|
1
|
1
|
2
|
2
|
5
|
2
|
2
|
2
|
|
| Total Current Assets |
4
|
6
|
6
|
21
|
31
|
14
|
11
|
9
|
15
|
15
|
13
|
14
|
14
|
34
|
38
|
37
|
31
|
47
|
55
|
58
|
42
|
34
|
33
|
35
|
|
| PP&E Net |
1
|
1
|
2
|
2
|
4
|
6
|
7
|
7
|
9
|
9
|
8
|
7
|
7
|
9
|
10
|
10
|
10
|
11
|
20
|
20
|
20
|
23
|
24
|
24
|
|
| PP&E Gross |
1
|
1
|
2
|
2
|
4
|
6
|
7
|
7
|
9
|
9
|
8
|
7
|
7
|
9
|
10
|
10
|
10
|
11
|
20
|
20
|
20
|
23
|
24
|
24
|
|
| Accumulated Depreciation |
3
|
3
|
4
|
4
|
5
|
4
|
4
|
6
|
6
|
8
|
9
|
10
|
11
|
12
|
13
|
13
|
14
|
15
|
18
|
21
|
25
|
27
|
31
|
33
|
|
| Intangible Assets |
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
1
|
1
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
2
|
2
|
1
|
1
|
|
| Goodwill |
5
|
3
|
3
|
3
|
2
|
2
|
2
|
3
|
3
|
3
|
2
|
3
|
2
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
4
|
5
|
5
|
6
|
6
|
6
|
5
|
5
|
3
|
3
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
|
| Other Assets |
5
|
3
|
3
|
3
|
2
|
2
|
2
|
3
|
3
|
3
|
2
|
3
|
2
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
|
| Total Assets |
10
N/A
|
11
+15%
|
11
+1%
|
27
+137%
|
38
+42%
|
24
-38%
|
23
-2%
|
22
-5%
|
29
+32%
|
31
+5%
|
28
-9%
|
29
+4%
|
28
-2%
|
51
+79%
|
57
+12%
|
57
+1%
|
51
-11%
|
68
+34%
|
86
+26%
|
88
+2%
|
73
-17%
|
67
-8%
|
66
-1%
|
68
+2%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
1
|
1
|
1
|
1
|
2
|
5
|
2
|
4
|
4
|
4
|
3
|
3
|
2
|
3
|
3
|
3
|
3
|
4
|
2
|
3
|
4
|
21
|
4
|
18
|
|
| Accrued Liabilities |
2
|
2
|
2
|
4
|
3
|
6
|
2
|
5
|
5
|
4
|
4
|
3
|
4
|
4
|
8
|
10
|
10
|
11
|
13
|
14
|
11
|
12
|
9
|
8
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
1
|
0
|
0
|
0
|
0
|
2
|
12
|
1
|
3
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
|
| Other Current Liabilities |
1
|
1
|
1
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
0
|
1
|
0
|
0
|
1
|
1
|
0
|
1
|
1
|
0
|
0
|
0
|
4
|
13
|
|
| Total Current Liabilities |
5
|
4
|
4
|
6
|
5
|
11
|
8
|
22
|
10
|
11
|
8
|
8
|
6
|
7
|
13
|
14
|
15
|
17
|
18
|
18
|
18
|
19
|
19
|
27
|
|
| Long-Term Debt |
8
|
1
|
1
|
0
|
0
|
2
|
23
|
19
|
11
|
12
|
0
|
0
|
0
|
1
|
3
|
3
|
2
|
2
|
10
|
9
|
8
|
34
|
29
|
58
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
1
|
1
|
0
|
0
|
0
|
2
|
3
|
4
|
5
|
5
|
5
|
7
|
7
|
7
|
10
|
10
|
11
|
12
|
14
|
11
|
8
|
11
|
11
|
10
|
|
| Total Liabilities |
16
N/A
|
6
-65%
|
5
-15%
|
7
+38%
|
5
-21%
|
15
+194%
|
34
+126%
|
45
+31%
|
25
-44%
|
28
+13%
|
13
-54%
|
14
+9%
|
13
-7%
|
16
+22%
|
26
+62%
|
27
+3%
|
28
+3%
|
31
+11%
|
42
+37%
|
40
-7%
|
35
-11%
|
65
+84%
|
59
-9%
|
96
+62%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
5
|
5
|
|
| Retained Earnings |
40
|
35
|
6
|
5
|
1
|
25
|
44
|
56
|
56
|
59
|
55
|
55
|
54
|
59
|
73
|
73
|
80
|
76
|
70
|
65
|
76
|
118
|
153
|
189
|
|
| Additional Paid In Capital |
33
|
40
|
0
|
15
|
33
|
33
|
33
|
33
|
59
|
59
|
68
|
68
|
68
|
91
|
102
|
102
|
102
|
113
|
113
|
113
|
113
|
119
|
155
|
155
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
2
|
2
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Total Equity |
6
N/A
|
6
N/A
|
6
+16%
|
20
+211%
|
33
+63%
|
8
-74%
|
11
N/A
|
23
-105%
|
4
N/A
|
2
-45%
|
15
+582%
|
15
+1%
|
15
+3%
|
34
+129%
|
30
-12%
|
30
-1%
|
23
-23%
|
38
+63%
|
44
+17%
|
49
+11%
|
38
-22%
|
2
-95%
|
7
+256%
|
28
N/A
|
|
| Total Liabilities & Equity |
10
N/A
|
11
+15%
|
11
+1%
|
27
+137%
|
38
+42%
|
24
-38%
|
23
-2%
|
22
-5%
|
29
+32%
|
31
+5%
|
28
-9%
|
29
+4%
|
28
-2%
|
51
+79%
|
57
+12%
|
57
+1%
|
51
-11%
|
68
+34%
|
86
+26%
|
88
+2%
|
73
-17%
|
67
-8%
|
66
-1%
|
68
+2%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
36
|
41
|
41
|
63
|
82
|
82
|
82
|
82
|
311
|
311
|
407
|
410
|
410
|
546
|
589
|
594
|
596
|
636
|
637
|
1 416
|
1 421
|
1 497
|
4 766
|
4 766
|
|
Switch to:
Switch to:
See Also
Discover More
